Bruker Corporation— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$977M
↓-0.2% -$2Mvs FY2024 (Q4)
Gross Profit
$449M
↓-8.9% -$44Mvs FY2024 (Q4)
Operating Income
$76M
↑+5.8% +$4Mvs FY2024 (Q4)
Net Income
$26M
↑+89.8% +$12Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $977M | $980M |
| COGS | $528M | $486M |
| Gross Profit | $449M | $493M |
| R&D | $100M | $104M |
| SG&A | $247M | $247M |
| D&A | $26M | $53M |
| Other OpEx | $0 | $17M |
| Operating Income | $76M | $72M |
| Interest Exp. | $8M | $16M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $68M | $56M |
| Tax | $42M | $42M |
| Net Income | $26M | $14M |
QuarterCharts · SEC EDGAR data · BRKR · Comparing FY2025 (Q4) vs FY2024 (Q4)